A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2001 AND VI 19 AND IP 10
Results: 16
1
2
The Burden of Asthma and Chronic Obstructive Pulmonary Disease: Data from The Netherlands.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 1, doi. 10.2165/00019053-200119002-00001
- By:
- Publication type:
- Article
3
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.
- Published in:
- 2001
- By:
- Publication type:
- journal article
4
Barrett's oesophagus: a review of costs of the illness.
- Published in:
- 2001
- By:
- Publication type:
- journal article
5
Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
6
Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls.
- Published in:
- 2001
- By:
- Publication type:
- journal article
7
Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective.
- Published in:
- 2001
- By:
- Publication type:
- journal article
8
Using Clinical Measures of Disease Control to Reduce the Burden of Asthma.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 7, doi. 10.2165/00019053-200119002-00002
- By:
- Publication type:
- Article
9
Using Humanistic Health Outcomes Data in Asthma.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 13, doi. 10.2165/00019053-200119002-00003
- By:
- Publication type:
- Article
10
Using Economic Evaluations to Reduce the Burden of Asthma and Chronic Obstructive Pulmonary Disease.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 21, doi. 10.2165/00019053-200119002-00004
- By:
- Publication type:
- Article
11
Using Health Outcomes Data to Inform Decision-Making: A Pharmaceutical Industry Perspective.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 27, doi. 10.2165/00019053-200119002-00005
- By:
- Publication type:
- Article
12
Using Health Outcomes Data to Inform Decision-Making The views expressed in this paper are those of the author and not the National Institute of Clinical Excellence (NICE).: Government Agency Perspective.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 33, doi. 10.2165/00019053-200119002-00006
- By:
- Publication type:
- Article
13
Using Health Outcomes Data to Inform Decision-Making: Healthcare Payer Perspective.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 39, doi. 10.2165/00019053-200119002-00007
- By:
- Publication type:
- Article
14
Using Health Outcomes Data to Inform Decision-Making: Formulary Committee Perspective.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 49, doi. 10.2165/00019053-200119002-00008
- By:
- Publication type:
- Article
15
Using Health Outcomes Data to Inform Decision-Making: Patient Perspective.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 53, doi. 10.2165/00019053-200119002-00009
- By:
- Publication type:
- Article
16
The Way Forward in the Care of Respiratory Diseases: Promoting Best Practice in Health Outcomes Research.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 10, p. 57, doi. 10.2165/00019053-200119002-00010
- By:
- Publication type:
- Article